NASDAQ$COO
The Cooper Companies Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
CooperCompanies reported strong third-quarter results with record revenues driven by CooperVision and CooperSurgical.
CooperCompanies announced a strong third quarter with revenue increasing by 32% year-over-year to $763.4 million. Both CooperVision and CooperSurgical experienced record revenues, contributing to record earnings and robust free cash flow. GAAP diluted earnings per share reached $12.37, while non-GAAP diluted earnings per share was $3.41, a 50% increase from the previous year.
- Revenue increased 32% year-over-year to $763.4 million.
- CooperVision (CVI) revenue was up 24% to $557.5 million.
- CooperSurgical (CSI) revenue was up 60% to $205.9 million.
- Non-GAAP diluted earnings per share was $3.41, up 50% from last year's third quarter.
Headline financials
Revenue & EPS history
Cooper · Revenue · Quarterly
$763M
Revenue by segment
Cooper · $206M total across 2 segments · Q3 2021
- Office and Surgical$123M+49.9%59.5%
- Fertility$83.4M+76.7%40.5%
Forward guidance
CooperCompanies updated its fiscal year 2021 financial guidance, while still viewing resurgences as a significant risk factor to our outlook.
Tailwinds
- Fiscal 2021 total revenue $2,893- $2,923 million (16% to 18% constant currency)
- CVI revenue $2,127 - $2,147 million (12% to 13% constant currency)
- CSI revenue $766 - $776 million (29% to 31% constant currency)
- Fiscal 2021 non-GAAP diluted EPS $13.20 - $13.40
- Fiscal fourth quarter 2021 total revenue $730 - $760 million (7% to 11% constant currency)
Headwinds
- CVI revenue $540 - $560 million (6% to 10% constant currency)
- CSI revenue $190 - $200 million (9% to 14% constant currency)
- Fiscal fourth quarter 2021 non-GAAP diluted EPS $3.24 - $3.44
- The Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses
- resurgences as a significant risk factor to our outlook
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+0.5%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.1%
Avg return
30 days after
51%
35 / 68 earnings
Positive
+12.1%
Q3 2024
Best reaction
-12.8%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.6% | -8.0% | -12.5% | |
| Q4 2025 | -4.3% | +4.8% | +5.3% | |
| Q3 2025 | -12.8% | -11.8% | -8.9% | |
| Q2 2025 | +0.0% | -0.3% | +3.6% | |
| Q1 2025 | -6.6% | -13.1% | -18.9% | |
| Q4 2024 | -6.0% | -5.6% | -12.6% | |
| Q3 2024 | +12.1% | +12.1% | +16.4% | |
| Q2 2024 | +3.5% | +3.8% | -4.2% | |
| Q1 2024 | +8.1% | +7.3% | +7.4% | |
| Q4 2023 | -2.2% | -0.7% | +6.8% | |
| Q3 2023 | -2.1% | -3.5% | -15.9% | |
| Q2 2023 | -4.0% | -5.1% | +3.2% | |
| Q1 2023 | +8.7% | +3.9% | +15.4% | |
| Q4 2022 | -1.6% | +4.8% | +9.7% | |
| Q3 2022 | +4.1% | +2.5% | -8.5% | |
| Q2 2022 | -0.3% | +1.3% | -7.2% | |
| Q1 2022 | +2.1% | -8.5% | +3.1% | |
| Q4 2021 | +4.8% | +8.7% | +12.2% | |
| Q3 2021 | +1.1% | -0.7% | -7.6% | |
| Q2 2021 | -0.7% | -3.2% | +6.0% | |
| Q1 2021 | +1.8% | +0.3% | +1.1% | |
| Q4 2020 | +3.3% | +3.3% | +8.6% | |
| Q3 2020 | +2.0% | +0.3% | +5.7% | |
| Q2 2020 | -0.2% | -5.0% | -9.1% | |
| Q1 2020 | -1.3% | -0.9% | -17.3% | |
| Q4 2019 | -1.6% | -2.4% | +3.3% | |
| Q3 2019 | -3.5% | -6.7% | -8.3% | |
| Q2 2019 | +4.5% | +9.0% | +18.2% | |
| Q1 2019 | -1.8% | +0.1% | +1.0% | |
| Q4 2018 | -11.6% | -7.3% | -10.4% | |
| Q3 2018 | -3.7% | -3.4% | +4.3% | |
| Q2 2018 | +1.4% | -0.4% | +6.0% | |
| Q1 2018 | +2.1% | -3.8% | -11.5% | |
| Q4 2017 | -3.2% | -1.9% | -1.5% | |
| Q3 2017 | -4.0% | -2.5% | -3.7% | |
| Q2 2017 | +8.9% | +10.5% | +9.4% | |
| Q1 2017 | -3.1% | -3.6% | -0.4% | |
| Q4 2016 | +1.3% | +4.1% | +5.2% | |
| Q3 2016 | +0.0% | +1.3% | -3.6% | |
| Q2 2016 | -0.1% | -0.4% | +7.1% | |
| Q1 2016 | +6.4% | — | — | |
| Q4 2015 | -12.8% | — | — | |
| Q3 2015 | -7.1% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | +9.7% | — | — | |
| Q4 2014 | -4.4% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.7% | — | — | |
| Q1 2014 | +4.3% | — | — | |
| Q4 2013 | -4.6% | — | — | |
| Q3 2013 | -1.8% | — | — | |
| Q2 2013 | +8.1% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.3% | — | — | |
| Q2 2012 | -4.1% | — | — | |
| Q1 2012 | +2.8% | — | — | |
| Q4 2008 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q2 2011 | +1.4% | — | — | |
| Q2 2010 | +1.4% | — | — | |
| Q1 2010 | +8.9% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q3 2010 | +5.8% | — | — | |
| Q3 2009 | +5.8% | — | — | |
| Q4 2009 | +5.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro